Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline

被引:13
|
作者
Lamar, Melissa [1 ,2 ]
Leurgans, Sue [1 ,3 ]
Kapasi, Alifiya [1 ,4 ]
Barnes, Lisa L. [1 ,2 ,3 ]
Boyle, Patricia A. [1 ,2 ]
Bennett, David A. [1 ,3 ]
Arfanakis, Konstantinos [1 ,5 ,6 ]
Schneider, Julie A. [1 ,3 ,4 ]
机构
[1] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, 1750 W Harrison St,Suite 1000, Chicago, IL 60612 USA
[2] Rush Univ, Dept Psychiat & Behav Sci, Med Ctr, Chicago, IL 60612 USA
[3] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA
[4] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA
[5] Rush Univ, Dept Diagnost Radiol & Nucl Med, Med Ctr, Chicago, IL 60612 USA
[6] IIT, Dept Biomed Engn, Chicago, IL 60616 USA
基金
美国国家卫生研究院;
关键词
arteriolosclerosis; atherosclerosis; comorbidity; dementia; neuropathology; CEREBRAL AMYLOID ANGIOPATHY; ALZHEIMERS-DISEASE; CLINICAL-DIAGNOSIS; RISK-FACTORS; RUSH MEMORY; DEMENTIA; NEUROPATHOLOGY; COMMUNITY; ASSOCIATION; INFARCTS;
D O I
10.1161/STROKEAHA.121.034814
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: Cerebrovascular disease (CVD) pathologies including vessel disease (atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy) and tissue injury (macroinfarcts and microinfarcts) each contribute to Alzheimer and other forms of dementia. CVD is often a complex mix of neuropathologies, with little known about the frequencies of differing combinations or their associations with cognition. Methods: We investigated 32 possible CVD combinations (3 types of vessel disease and 2 types of tissue injury) using autopsy data from 1474 decedents (approximate to 88 years at death; 65% female) of Rush Alzheimer's Disease Center studies. We determined frequencies of all 32 CVD combinations and their relationships with global and domain-specific cognitive decline using mixed-effect models adjusted for demographics, neuropathologies, time before death, and interactions of these variables with time. Results: Of the 1184 decedents with CVD neuropathology (80% of the total sample), 37% had a single CVD (67-148 decedents/group) while 63% had mixed CVD profiles (11-54 decedents/group). When considered as 2 distinct groups, the mixed CVD profile group (but not the single CVD profile group) showed a faster cognitive decline across all domains assessed compared with decedents without CVD neuropathology. Most mixed CVD profiles, especially those involving both atherosclerosis and arteriolosclerosis, showed faster cognitive decline than any single CVD profile considered alone; specific mixed CVD profiles differentially associated with individual cognitive domains. Conclusions: Mixed CVD, more common than single CVD, is associated with cognitive decline, and distinct mixed CVD profiles show domain-specific associations with cognitive decline. CVD is not monolithic but consists of heterogenous person-specific combinations with distinct contributions to cognitive decline.
引用
收藏
页码:218 / 227
页数:10
相关论文
共 50 条
  • [21] Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease
    Jeong, Ho Tae
    Sung, Hyun-Ho
    Lee, Jun Hong
    Park, Kwang-Yeol
    Youn, Young Chul
    [J]. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (06) : 595 - 600
  • [22] Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease
    Ho Tae Jeong
    Hyun-Ho Sung
    Jun Hong Lee
    Kwang-Yeol Park
    Young Chul Youn
    [J]. High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 595 - 600
  • [23] Parkinson's disease with, but not without, cognitive decline reveals advanced brain aging
    Kuo, M. C.
    Chen, C. L.
    Wu, R. M.
    Tseng, W. Y.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S361 - S362
  • [24] Spreading Pathologies Precede Cognitive Decline in Alzheimer's Disease
    Howlett, David R.
    Attems, Johannes
    Francis, Paul T.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (08) : 678 - 679
  • [25] Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease
    Kuczynski, Beth
    Reed, Bruce
    Mungas, Dan
    Weiner, Michael
    Chui, Helena C.
    Jagust, William
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (05) : 650 - 655
  • [26] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [27] D-galactose-induced aging does not cause further deterioration in brain pathologies and cognitive decline in the obese condition
    Shwe, Thazin
    Bo-Htay, Cherry
    Leech, Tom
    Ongnok, Benjamin
    Jaiwongkum, Thidarat
    Kerdphoo, Sasiwan
    Palee, Siripong
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    [J]. EXPERIMENTAL GERONTOLOGY, 2020, 138
  • [28] Relationship between physical activity and cognitive decline in aging
    Iuliano, Enzo
    Di Cagno, Alessandra
    Aquino, Giovanna
    Pistone, Eugenio M.
    Tsopani, Despina
    Calcagno, Giuseppe
    Di Costanzo, Alfonso
    Fiorilli, Giovanni
    [J]. MEDICINA DELLO SPORT, 2016, 69 (01) : 151 - 161
  • [29] COGNITIVE DECLINE IN AGING BRAIN - THERAPEUTIC APPROACH WITH PHOSPHATIDYLSERINE
    SINFORIANI, E
    AGOSTINIS, C
    MERLO, P
    GUALTIERI, S
    MAURI, M
    MANCUSO, A
    [J]. CLINICAL TRIALS JOURNAL, 1987, 24 (01) : 115 - 124
  • [30] Fitness and Cognitive Decline of the Aging Brain - A Preliminary Investigation
    Savin-Murphy, Janet
    Zimmerman, Jo B.
    Deeny, Sean P.
    Ludlow, Andrew T.
    Poeppel, David
    Roth, Stephen M.
    Contreras-Vidal, Jose
    Hatfield, Bradley D.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (05): : S90 - S90